Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

In full: Rishi Sunak's letter to the sector

What did the Prime Minister have to say in his letter of support to the sector? See the full text of his letter to the Sigma 2023 UK community pharmacy conference below

It gives me great pleasure to send a message of encouragement and support to those attending the annual Sigma UK Community Pharmacy Conference.

 

The government very much appreciates the hard work of our pharmacy teams and we want to enable them to do more to support the NHS.

 

Read more: ‘Not unnoticed’: Sunak issues letter of support to community pharmacy


Community pharmacies play such an important role in maintaining and looking after local communities and I want to extend my personal gratitude to everyone who provides these services daily. Your incredible work does not go unnoticed.

 

Earlier this year, the government announced a further investment of up to £645million over the next two years to support the Pharmacy First service for patients.

 

Read more: Our new PM is the son of a pharmacist – but will he cough up the cash?

This means that community pharmacists will be able to initially assess a patient and provide some options for treatment, without a GP's appointment. This will be an important addition to the work pharmacies already do, proving how valuable and trusted you are within your communities.

 

I wish you all a successful conference and hope that all those attending feel recognised for the work they do to look after our health.

Related Content

Topics

         
Pharmacist Manager
Oxford
£ Competitive

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD137396

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel